Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B1124 Pitavastatin2 CitationSummary: HMG-CoA reductase inhibitor -
B1125 PravastatinSummary: HMG-CoA reductase inhibitor against sterol synthesis -
B1165 Pimobendan hydrochlorideSummary: Selective inhibitor of PDE3 -
B1947 GemfibrozilSummary: PPARα activator -
B1676 Benzoic AcidSummary: Organic aromatic monocarboxylic acid -
B1727 DibenzothiopheneSummary: Organically synthesized intermediate -
B1871 ZoxazolamineSummary: Uricosuric and muscle relaxant -
B8041 2-Deoxyadenosine 5-diphosphate -
A4733 DL-GlutamineSummary: A mixture of amino acids composed of the two enantiomers D-glutamine and L-glutamine -
A9036 Hydronidone

